Antimicrobial resistance is a relevant “One Health” issue that shows the need of comparison of isolates of different origins. In this way, guidelines for antimicrobial-resistance evaluation in animals are relevant in relation to human sources. This work aims to compare antimicrobial-resistance results of animal isolates considering CLSI and EUCAST guidelines. The comparison shows considerable differences in the results, which include antibiotics used as primary options in hospital infections. EUCAST showed the higher number of samples with resistance profiles than CLSI that indicates a more efficient scenario to the EUCAST to screen antibiotic-resistant bacteria. EUCAST was more consonant to the expected phenotype for ESBL producers, with h...
[Objectives] To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUC...
Background: Pyometra is a diestrual chronic disease frequently associated with Escherichia coli. Ini...
To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUCAST methodolo...
WOS: 000464106600008Objective: Our aim in this study is to compare the Clinical Laboratory Standards...
Objectives The aim of this study was to analyse the effects of clinical breakpoint changes in CLSI 2...
Background: The Clinical Laboratory Standards Institute (CLSI) and the European Committee on Antimic...
Objectives To compare the performance of European Committee on Antimicrobial Susceptibility Testing ...
EUCAST breakpoint criteria are being adopted by automatic antimicrobial susceptibility testing syste...
Objectives This study aimed to: (i) analyse the antibiotic susceptibility testing (AST) profiles of ...
AbstractEUCAST breakpoint criteria are being adopted by automatic antimicrobial susceptibility testi...
A challenge panel of bacterial strains useful for clinical laboratories to validate their European C...
OBJECTIVE:We studied whether the change in antibiotic susceptibility testing (AST) guidelines from C...
Objectives: To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUCA...
(EUCAST) and CLSI breakpoints following their revision in 2010, for the detection of extended-spectr...
Darba mērķis bija salīdzināt EUCAST un CLSI antimikrobās jutības noteikšanas metodes paplašināta spe...
[Objectives] To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUC...
Background: Pyometra is a diestrual chronic disease frequently associated with Escherichia coli. Ini...
To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUCAST methodolo...
WOS: 000464106600008Objective: Our aim in this study is to compare the Clinical Laboratory Standards...
Objectives The aim of this study was to analyse the effects of clinical breakpoint changes in CLSI 2...
Background: The Clinical Laboratory Standards Institute (CLSI) and the European Committee on Antimic...
Objectives To compare the performance of European Committee on Antimicrobial Susceptibility Testing ...
EUCAST breakpoint criteria are being adopted by automatic antimicrobial susceptibility testing syste...
Objectives This study aimed to: (i) analyse the antibiotic susceptibility testing (AST) profiles of ...
AbstractEUCAST breakpoint criteria are being adopted by automatic antimicrobial susceptibility testi...
A challenge panel of bacterial strains useful for clinical laboratories to validate their European C...
OBJECTIVE:We studied whether the change in antibiotic susceptibility testing (AST) guidelines from C...
Objectives: To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUCA...
(EUCAST) and CLSI breakpoints following their revision in 2010, for the detection of extended-spectr...
Darba mērķis bija salīdzināt EUCAST un CLSI antimikrobās jutības noteikšanas metodes paplašināta spe...
[Objectives] To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUC...
Background: Pyometra is a diestrual chronic disease frequently associated with Escherichia coli. Ini...
To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUCAST methodolo...